99% CAS 73536-69-3 Bifendate Pharmaceutical Bifendate Ingredient Bifendate

China 99% CAS 73536-69-3 Bifendate Pharmaceutical Bifendate Ingredient Bifendate, Find details about China Bifendate, Bifendate Powder from 99% CAS 73536-69-3 Bifendate Pharmaceutical Bifendate Ingredient Bifendate

Basic Info.

Model NO.

Condavo-Bifendate

Name

Bifendate

Product Name

Bifendate Powder

Appearance

White Powder

Color

White Color

Test Method

HPLC UV

Storage

Cool Dry Place

Shelf Life

2 Years

Assay

99%

CAS

73536-69-3

C20h18o10

418.354

Density

1.39

Boiling Point

606.9c at 760 Mmhg

Refractive Index

1.579

Flash Point

265.9c

Trademark

Condavo

Transport Package

1kg/ Aluminium Bag or 25kg/Drum; as Required

Specification

99%

Origin

Shaanxi

Model NO.

Condavo-Bifendate

Name

Bifendate

Product Name

Bifendate Powder

Appearance

White Powder

Color

White Color

Test Method

HPLC UV

Storage

Cool Dry Place

Shelf Life

2 Years

Assay

99%

CAS

73536-69-3

C20h18o10

418.354

Density

1.39

Boiling Point

606.9c at 760 Mmhg

Refractive Index

1.579

Flash Point

265.9c

Trademark

Condavo

Transport Package

1kg/ Aluminium Bag or 25kg/Drum; as Required

Specification

99%

Origin

Shaanxi

Product Desciption

99% CAS 73536-69-3 Bifendate Pharmaceutical Bifendate Ingredient Bifendate

99% CAS 73536-69-3 Bifendate Pharmaceutical Bifendate Ingredient Bifendate

Product Name	Bifendate
CAS	73536-69-3
Appearance	White crystalline powder
MF	C20H18O10
MW	418.354
Purity	99%
Shelf Life	2 Years

Bifendate is a synthetic intermediate of Schisandrin C and also an anti-HBV drug used in Chinese medicine for the treatment of chronic hepatitis B. Following the intake of Bifendate in rats, the drug was observed to improve liver function by increasing the detoxification process, reducing pathological lesions, and accelerating hepatocyte regeneration. Bifendate can also function as a membrane-stabilizing agent to protect the cell from damage. After treatment with Bifendate, the protein metabolic processes of hepatitis patients were improved, with increased serum albumin levels and decreased globulin levels. Bifendate is a potent inducer of cytochrome proteins (CYPs) and can result in clinically significant interactions. It has been proposed that the increased detoxification capability of Bifendate originates from an increase in the level of P450. Bifendate may function as a protecting agent to prevent drug-induced liver dysfunction by increasing the activity of CYP450.

99% CAS 73536-69-3 Bifendate Pharmaceutical Bifendate Ingredient Bifendate

99% CAS 73536-69-3 Bifendate Pharmaceutical Bifendate Ingredient Bifendate Bifendate is a synthetic intermediate of Schisandrin C and also an anti-HBV drug used in Chinese medicine for the treatment of chronic hepatitis B.

Common drugs for the treatment of elevated transaminase caused by viral hepatitis and drug-induced liver injury. In the past, it was considered that it has the pharmacological effect of protecting hepatocytes and increasing the detoxification function of liver.

99% CAS 73536-69-3 Bifendate Pharmaceutical Bifendate Ingredient Bifendate